ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today announced it will issue third quarter financial results before the opening of the market on Monday, November 9, 2009. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. EST.
The conference call can be accessed by dialing 888-466-4587 (domestic calls) or 719-325-2352 (international calls) at 9:45 a.m. EST and entering passcode 7298934. The webcast will be available live via the Internet and can be accessed on the company's website at www.amriglobal.com. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at www.amriglobal.com/investor_relations/.
Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.
Albany Molecular Research, Inc.
Investor
Peter Jerome,
518-512-2220
Director of Investor Relations
or
Media
Andrea
Schulz, 518-512-2226
Director of Corporate Communications
158.94 (1.43%)
